Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +49.35%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +24.17%
#5 Nockchain Nockchain +15.10%
#6 FOLKS FOLKS +14.14%
#7 Tutorial Tutorial +13.69%
#8 Humanity Humanity +13.15%
#9 Velvet Velvet +13.00%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Classifica tra le azioni #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Prezzo delle azioni
$0.1
Ultima sincronizzazione: 2024-06-18
Capitalizzazione di mercato
$1.31M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Pascal Biosciences Inc. (PSCBF)

Categoria

Healthcare
Storico del prezzo dell'azione per Pascal Biosciences Inc. (PSCBF)
Prezzo di chiusura più alto: $0.11 il 2024-06-01

Prezzo di chiusura più basso: $0.00 il 2015-02-01
Storico del prezzo dell'azione di Pascal Biosciences Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 93.04%
2023 -27.07%
2022 1,834.12%
2021 104,999.10%
2020 253,573.91%
2019 93.68%
2018 -5.21%
2017 177.10%
2016 41.58%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE